Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 2245 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

LETTER TO THE EDITOR Table of Contents   
Year : 2009  |  Volume : 20  |  Issue : 5  |  Page : 848-849
Primary cutaneous aspergillosis in renal transplant recipient

1 epartment of Nephrology, All India Institute of Medical Sciences, New Delhi, India
2 Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

Click here for correspondence address and email

Date of Web Publication2-Sep-2009

How to cite this article:
Gupta A, Khaira A, Lata S, Sharma A, Tiwari SC. Primary cutaneous aspergillosis in renal transplant recipient. Saudi J Kidney Dis Transpl 2009;20:848-9

How to cite this URL:
Gupta A, Khaira A, Lata S, Sharma A, Tiwari SC. Primary cutaneous aspergillosis in renal transplant recipient. Saudi J Kidney Dis Transpl [serial online] 2009 [cited 2022 Sep 26];20:848-9. Available from: https://www.sjkdt.org/text.asp?2009/20/5/848/55376
To the Editor,

A 45 year-old renal transplant recipient pre­sented with nodular swelling over postero-lateral right calf for 10 days. He had good graft func­tion on prednisolone 7.5 mg/day, tacrolimus 2 mg/day and mycophenolate mofetil 1 g/day after 18 months of transplantation. Examina­tion showed tender and warm nodule 3 × 5 cm in size, along with a discharging sinus. No si­milar nodules were present elsewhere. Syste­mic examination was normal. Investigations showed normal absolute neutrophilic count, blood glucose and chest X-ray. Tacrolimus trough (T0) level was 12.80 ng/mL. Cultures for bacteria, fungus and acid fast bacilli were negative from the discharging sinus. Biopsy of the lesion revealed neutrophilic micro-abscesses with acute angle branching and slender septate fungal protoles compatible with Aspergillus species [Figure 1]. Tablet itraconazole 200 mg/day was started and tacrolimus was re­duced to 1.0 mg/day. Surgical excision was deferred since the lesion started to resolve and disappeared in 4 weeks. Repeat T0 level after 2 weeks was 5.08 ng/mL. The patient was given 12 weeks of itraconazole and followed under close supervision. There was no recu­rrence or new lesions.

Aspergillosis usually occurs in an immuno­compromised host. Commonly involved sites are lung, brain, heart, kidney, thyroid, intestines and skin in descending order of frequency. The literature is deplete with reports of primary cutaneous Aspergillosis. [1],[2] Biopsy and culture confirmation is needed to differentiate Asper­gillus species from other filamentous fungi. Cultures from the tissue were not done as fungus was not expected initially.

In cutaneous Aspergillosis, voriconazole is recommended as the first line agent and itra­conazole is an alternative agent; however the duration of treatment is not well defined. [3] We treated the patient with itraconazole due to financial constrains and obtained a gratifying response. A similar response was observed by Prasad et al in a case of cutaneous Asper­gillosis after one month therapy with itraco­nazole. [4] Since itraconazole is well concentra­ted in skin structures, and is cheap, it may be the drug of choice in skin limited cases. We reduced tacrolimus in view of high trough levels and its interaction with itraconazole. [5] Although the treatment duration has not been well defined, we feel that the patient should be treated for at least 3 months and followed up closely. This letter highlights the above men­tioned facts which a renal transplant physician in developing countries needs to be aware of.

   References Top

1.Thomas LM, Rand HK, Miller JL, Boyd AS. Primary cutaneous Aspergillosis in a patient with solid organ transplantation: case report and review of the literature. Cutis 2008;81: 127-30.  Back to cited text no. 1  [PUBMED]  
2.Mallat SG, Aoun M, Moussalli A, Chelala D, Moukarzel M. Cutaneous aspergillosis in a renal transplant recipient. J Med Liban 2004; 52:111-4.  Back to cited text no. 2  [PUBMED]  
3.Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis 2008;46:327-60.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Prasad PV, Babu A, Kaviarasan PK, Anandhi C, Viswanathan P. Primary cutaneous aspergillosis. Indian J Dermatol Venereol Leprol 2005;71: 133-4.  Back to cited text no. 4  [PUBMED]  Medknow Journal
5.Ideura T, Muramatsu T, Higuchi M, Tachibana N, Hora K, Kiyosawa K. Tacrolimus/Itraco­nazole Interactions: A case report of ABO­incompatible living- related renal transplan­tation. Nephrol Dial Transplant 2000;15:1721-3.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]

Correspondence Address:
Ankur Gupta
epartment of Nephrology, All India Institute of Medical Sciences, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 19736488

Rights and PermissionsRights and Permissions


  [Figure 1]

This article has been cited by
1 A solitary erythematous nodule in a 62-year-old man
Rhodes, J.E. and Clay, C.D. and Heath, C.H.
Clinical and Experimental Dermatology. 2012; 37(5): 576-577
2 Nonneoplastic mucocutaneous lesions in organ transplant recipients
Ponticelli, C. and Bencini, P.L.
Transplant International. 2011; 24(11): 1041-1050


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  

    Article Figures

 Article Access Statistics
    PDF Downloaded393    
    Comments [Add]    
    Cited by others 2    

Recommend this journal